Low- and middle-income countries share the greatest burden of cancer mortality globally but lag behind high-income countries in terms of clinical trials. Here we discuss the challenges facing low- and middle-income countries and the opportunities for conducting trials of affordable, accessible and effective interventions relevant to the local population.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Trials Open Access 04 May 2021
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Bray, F., Jemal, A., Grey, N., Ferlay, J. & Forman, D. Lancet Oncol. 13, 790–801 (2012).
Allemani, C. et al. Lancet 385, 977–1010 (2015).
IARC. World Cancer Report 2014 (eds. Stewart, B.W. & Wild, C.P.) (IARC, 2014); http://publications.iarc.fr/Non-Series-Publications/World-Cancer-Reports/World-Cancer-Report-2014
Gyawali, B., Sullivan, R. & Booth, C. M. Lancet Oncol. 19, 288–290 (2018).
Heneghan, C. et al. BMJ Open 3, e003298 (2013).
Viergever, R. F. & Li, K. BMJ Open 5, e008932 (2015).
Tran, V. T. & Ravaud, P. BMC Med. 14, 102 (2016).
Fan, H. & Song, F. Sci. Rep. 5, 13221 (2015).
Trimble, E. L. et al. J. Clin. Oncol. 27, 5109–5114 (2009).
Wang, H. et al. Cancer https://doi.org/10.1002/cncr.29456 (2015).
Badwe, R. et al. J. Clin. Oncol. 29, 2845–2851 (2011).
Chinnock, P., Siegfried, N. & Clarke, M. PLoS Med. 2, e107 (2005).
DeMonaco, H. J., Ali, A. & Hippel, Ev Pharmacotherapy 26, 323–332 (2006).
D’Cruz, A. K. et al. N. Engl. J. Med. 373, 521–529 (2015).
Badwe, R. et al. Lancet Oncol. 16, 1380–1388 (2015).
Cavalli, F. & Atun, R. Lancet Oncol. 16, 133–134 (2015).
Pantziarka, P. et al. ecancer 12, 886 (2018).
Ali, R., Toh, H.-C. & Chia, W.-K., ASCOLT Trial Investigators. Trials 12, 261 (2011).
Lomas, J. Br. Med. J. 334, 129–132 (2007).
Degos, L. Br. J. Haematol. 122, 539–553 (2003).
Ferreccio, C. & Gage, J. Visual inspection of the uterine cervix with Acetic Acid (VIA): a critical review and selected articles (Pan American Health Organization, 2003); http://iris.paho.org/xmlui/handle/123456789/767
Coyle, C. et al. Contemp. Clin. Trials 51, 56–64 (2016).
Soria, J.-C. et al. Lancet 389, 917–929 (2017).
Prasad, V., Kumar, H. & Mailankody, S. J. Glob. Oncol. 2, 1–3 (2015).
Binagwaho, A., Wagner, C. M. & Farmer, P. E. J. Clin. Oncol. 34, 3–5 (2016).
We thank R. Viergever for sharing the codes for the estimation of the number of trials in HICs and LMICs6, and K. Beckers for help with the figure. B.G.’s work is supported by a Conquer Cancer Global Oncology Young Investigator Award. Any opinions, findings, and conclusions expressed in this material are those of the author(s) and do not necessarily reflect those of the American Society of Clinical Oncology or Conquer Cancer.
N.A. has consulting contract with Bristol-Myers Squibb, has received funding from Bristol-Myers Squibb for a trial as well as drugs for two trials, and has received drugs for a trial from Pierre Fabre.
About this article
Cite this article
Gyawali, B., Bouche, G., Crisp, N. et al. Challenges and opportunities for cancer clinical trials in low- and middle-income countries. Nat Cancer 1, 142–145 (2020). https://doi.org/10.1038/s43018-020-0030-x
This article is cited by
Nature Medicine (2022)
The challenges of implementing low-dose computed tomography for lung cancer screening in low- and middle-income countries
Nature Cancer (2020)